232 related articles for article (PubMed ID: 33843997)
1. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
[TBL] [Abstract][Full Text] [Related]
3. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
4. The impact of cumulative colorectal cancer screening delays: A simulation study.
Rutter CM; Inadomi JM; Maerzluft CE
J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841
[TBL] [Abstract][Full Text] [Related]
5. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Cervical and Colorectal Cancer Screenings During the Pandemic in Community Health Centers: Practice Changes and Recovery Strategies.
Huguet N; Danna M; Baron A; Hall J; Hodes T; O'Malley J; Holderness H; Marino M; DeVoe JE; Cohen DJ
Med Care; 2023 Aug; 61(8):554-561. PubMed ID: 37310241
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
9. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
[TBL] [Abstract][Full Text] [Related]
11. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
12. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
13. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
[TBL] [Abstract][Full Text] [Related]
14. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
Alba C; Zheng Z; Wadhera RK
JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
[TBL] [Abstract][Full Text] [Related]
15. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
18. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
Elife; 2023 Jan; 12():. PubMed ID: 36695411
[TBL] [Abstract][Full Text] [Related]
19. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
20. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]